GlassScriptPhysician profile
Regina C Lee
NPI 1164710083
$12,328.90
in general payments reported to CMS, 2019-2025
42 companies · $861 in 2025
The $861 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $251 · 2021: $198 · 2022: $402 · 2023: $8,304 · 2024: $985 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,095 · Food and Beverage: $3,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,095.38 |
| Food and Beverage | $3,054.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,852.98 | 2021-2025 | Resolute Onyx, Onyx Frontier, Aurora Ev-Icd Mri Surescan |
| Abiomed | $1,029.72 | 2022-2025 | Impella |
| Shockwave Medical, INC | $480.10 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $345.36 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Stents, Embold Fibered |
| Novartis Pharmaceuticals Corporation | $285.45 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $238.70 | 2019-2023 | Farxiga |
| Corindus INC. | $229.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $227.21 | 2019-2020 | |
| Cardiovascular Systems INC. | $177.28 | 2019-2021 | |
| Pfizer INC. | $165.36 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.62 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $145.60 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $111.64 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $82.65 | 2020 | |
| Braemar Manufacturing, LLC | $72.99 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.